Literature DB >> 12967525

Oxidative stress in systemic lupus erythematosus and antiphospholipid syndrome: a gateway to atherosclerosis.

José Delgado Alves1, Bruno Grima.   

Abstract

Vascular disease and atherosclerosis are significant clinical features of systemic lupus erythematosus and antiphospholipid syndrome. Oxidation is one of the major factors responsible for atheroma development in this context. Anticardiolipin antibodies seem to play an important role by inducing nitric oxide and superoxide production, resulting in enhanced levels of plasma peroxynitrite, which is a powerful pro-oxidant substance. Furthermore, direct interference of these antibodies with paraoxonase activity, a high-density lipoprotein-related anti-oxidant enzyme, would contribute to the oxidative stress found in these conditions. The accelerated process of atherogenesis found in these diseases can represent a useful model for the study of atherosclerosis in the general population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967525     DOI: 10.1007/s11926-003-0029-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  49 in total

1.  Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes.

Authors:  N Hyka; J M Dayer; C Modoux; T Kohno; C K Edwards; P Roux-Lombard; D Burger
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

2.  Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells.

Authors:  Christy-Lynn M Cooke; Sandra T Davidge
Journal:  Am J Physiol Cell Physiol       Date:  2002-02       Impact factor: 4.249

3.  Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity.

Authors:  R C Sorenson; C L Bisgaier; M Aviram; C Hsu; S Billecke; B N La Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

4.  Superoxide and peroxynitrite in atherosclerosis.

Authors:  C R White; T A Brock; L Y Chang; J Crapo; P Briscoe; D Ku; W A Bradley; S H Gianturco; J Gore; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

5.  Correlation of serum measures of nitric oxide production with lupus disease activity.

Authors:  G Gilkeson; C Cannon; J Oates; C Reilly; D Goldman; M Petri
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

6.  Nitric oxide donor compounds inhibit the toxicity of oxidized low-density lipoprotein to endothelial cells.

Authors:  A T Struck; N Hogg; J P Thomas; B Kalyanaraman
Journal:  FEBS Lett       Date:  1995-03-20       Impact factor: 4.124

7.  Prospective study of serum and urinary nitrate levels in patients with systemic lupus erythematosus.

Authors:  M R Gonzalez-Crespo; J A Navarro; J Arenas; E Martin-Mola; J De La Cruz; J J Gomez-Reino
Journal:  Br J Rheumatol       Date:  1998-09

8.  Stimulation of von Willebrand factor antigen release by immunoglobulin from thrombosis prone patients with systemic lupus erythematosus and the anti-phospholipid syndrome.

Authors:  N J Lindsey; R A Dawson; F I Henderson; M Greaves; P Hughes
Journal:  Br J Rheumatol       Date:  1993-02

Review 9.  Atherosclerosis and the antiphospholipid syndrome: a link unravelled?

Authors:  Y Shoenfeld; D Harats; J George
Journal:  Lupus       Date:  1998       Impact factor: 2.911

10.  The high-output nitric oxide pathway: role and regulation.

Authors:  Q Xie; C Nathan
Journal:  J Leukoc Biol       Date:  1994-11       Impact factor: 4.962

View more
  8 in total

Review 1.  Autophagy in immunity: implications in etiology of autoimmune/autoinflammatory diseases.

Authors:  Xu-Jie Zhou; Hong Zhang
Journal:  Autophagy       Date:  2012-08-14       Impact factor: 16.016

Review 2.  The pathophysiology of hypertension in systemic lupus erythematosus.

Authors:  Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-21       Impact factor: 3.619

Review 3.  New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.

Authors:  Chary Lopez-Pedrera; Nuria Barbarroja; Alejandra Mª Patiño-Trives; Eduardo Collantes; Mª Angeles Aguirre; Carlos Perez-Sanchez
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

Review 4.  Genetic and molecular biology of systemic lupus erythematosus among Iranian patients: an overview.

Authors:  Meisam Gachpazan; Iman Akhlaghipour; Hamid Reza Rahimi; Ehsan Saburi; Majid Mojarrad; Mohammad Reza Abbaszadegan; Meysam Moghbeli
Journal:  Auto Immun Highlights       Date:  2021-01-30

Review 5.  Therapeutic Potential and Immunomodulatory Role of Coenzyme Q10 and Its Analogues in Systemic Autoimmune Diseases.

Authors:  Chary López-Pedrera; José Manuel Villalba; Alejandra Mª Patiño-Trives; Maria Luque-Tévar; Nuria Barbarroja; Mª Ángeles Aguirre; Alejandro Escudero-Contreras; Carlos Pérez-Sánchez
Journal:  Antioxidants (Basel)       Date:  2021-04-13

6.  Antiphospholipid Antibodies From Women With Pregnancy Morbidity and Vascular Thrombosis Induce Endothelial Mitochondrial Dysfunction, mTOR Activation, and Autophagy.

Authors:  Carlos M Rodríguez; Manuela Velásquez-Berrío; Carolina Rúa; Marta Viana; Vikki M Abrahams; Angela P Cadavid; Angela M Alvarez
Journal:  Front Physiol       Date:  2021-11-29       Impact factor: 4.566

7.  'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'.

Authors:  C Pérez-Sánchez; M A Aguirre; P Ruiz-Limón; N Barbarroja; Y Jiménez-Gómez; I Arias de la Rosa; A Rodriguez-Ariza; E Collantes-Estévez; P Segui; F Velasco; M J Cuadrado; R Teruel; R González-Conejero; C Martínez; Ch López-Pedrera
Journal:  Sci Rep       Date:  2016-08-09       Impact factor: 4.379

8.  Association between plasmatic oxidative stress and thrombosis in primary antiphospholipid syndrome.

Authors:  Camila O Vaz; Bruna M Mazetto; Pedro Eduardo N S Vasconcelos; Larissa B Bastos; Maria Aparecida Cursino; Júlia Coelho França Quintanilha; Gabriela Lisiane Tripiquia Vechiatto Mesquita; Ana Paula R Santos; Bruna Cardoso Jacintho; José Diogo Oliveira; Joyce Annichino-Bizzachi; Fernanda A Orsi
Journal:  J Thromb Thrombolysis       Date:  2021-07-05       Impact factor: 2.300

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.